{"number":"US12697317B2","kindCode":"B2","documentType":"grant","title":{"original":"Dosages and uses of ornithine phenylacetate for treating hyperammonemia","english":"Dosages and uses of ornithine phenylacetate for treating hyperammonemia"},"abstract":{"original":"Embodiments of the present disclosure relate to doses of ornithine phenylacetate for treating or ameliorating hyperammonemia and the methods of administrating the same in a patient with a chronic liver disease, for example, cirrhosis. In some embodiments, the patient also has hepatic encephalopathy as a complication of the liver disease.","english":"Embodiments of the present disclosure relate to doses of ornithine phenylacetate for treating or ameliorating hyperammonemia and the methods of administrating the same in a patient with a chronic liver disease, for example, cirrhosis. In some embodiments, the patient also has hepatic encephalopathy as a complication of the liver disease."},"applicants":["AMALIVE LIMITED"],"inventors":["Xiaofeng Wang Rears","Jack Tseng","Carmen Mak","Nagaraju Poola","Regis Vilchez","Aniruddha Potnis","Susan VanMeter","Jan Stange"],"filingDate":"2022-04-06","publicationDate":"2026-08-04","grantDate":"2026-08-04","verifiedWithOffice":true,"pdfUrl":"https://downloadpatent.com/pdf/US12697317B2.pdf","pages":{"en":"https://downloadpatent.com/patent/US12697317B2","zh-Hant":"https://downloadpatent.com/zh-Hant/patent/US12697317B2","ja":"https://downloadpatent.com/ja/patent/US12697317B2"}}